Pharma
How Eli Lilly’s oral GLP-1 could change the obesity drug market
A hot new GLP-1 bombshell has entered the villa.
Weight Loss
Retail Pharmacies
Walgreens enters the weight loss, telehealth markets
The pharmacy giant is offering virtual visits and access to GLP-1s.
Pharma
Big Pharma tackles Super Bowl advertising
This year’s game was punctuated by more pharma commercials, though some experts wonder if regulations might squash that momentum.
Pharma
GLP-1 manufacturers enter a turf war
The girls are fighting…again.
Pharma
What’s the difference between the GLP-1s on the market?
From semaglutide vs. tirzepatide to Ozempic vs. Wegovy.
Pharma
Eli Lilly, Novo Nordisk report strong earnings as GLP-1 race heats up
Both drugmakers saw strong YoY sales, though Novo’s GLP-1 sales were down slightly from Q4 2024.
Retail Pharmacies
Aetna to leave ACA marketplace while CVS partners with Novo Nordisk on Wegovy
It was a busy Q1 for the retail pharmacy giant.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
